Bragar Eagel & Squire, P.C. is investigating potential claims against The Ensign Group, Inc. on behalf of Ensign stockholders. The investigation concerns whether Ensign violated federal securities laws or engaged in other unlawful business practices. It follows a June 8, 2026 Hunterbrook short report alleging that Ensign's business model relies on inadequate patient care and gaming quality metrics, and that profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, resulting in patient suffering and death. After the report, Ensign's stock price fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026. Stockholders who purchased or acquired Ensign shares and suffered a loss are encouraged to contact the firm.
The Ensign Group IncInvestigation and short report alleging patient care failures and securities law violations.